Uterine Cervical Neoplasms
147
26
34
57
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
16 trials with published results (11%)
Research Maturity
57 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.5%
11 terminated out of 147 trials
83.8%
-2.8% vs benchmark
7%
11 trials in Phase 3/4
28%
16 of 57 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 57 completed trials
Clinical Trials (147)
HTL0039732 in Participants With Advanced Solid Tumours
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers
Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)
Epidemiological Landscape of Cervical Cancer in Latin America
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
Nudging Preventive Screening Via Message Framing and Bundling
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)